Exact Mass: 288.1810886
Exact Mass Matches: 288.1810886
Found 500 metabolites which its exact mass value is equals to given mass value 288.1810886,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dehydroepiandrosterone
Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue and the brain. DHEA is structurally similar to, and is a precursor of, androstenedione, testosterone, estradiol, estrone and estrogen. It is the most abundant hormone in the human body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate- DEHAS) before secretion. DHEAS is the sulfated version of DHEA; - this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEAS with levels that are about 300 times higher than free DHEA. Blood measurements of DHEAS/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEAS. [HMDB]. Dehydroepiandrosterone is found in many foods, some of which are summer grape, quinoa, calabash, and chinese chives. Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue, and the brain. DHEA is structurally similar to and is a precursor of, androstenedione, testosterone, estradiol, estrone, and estrogen. It is the most abundant hormone in the human body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate or DHEA-S) before secretion. DHEA-S is the sulfated version of DHEA; this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEA-S with levels that are about 300 times higher than free DHEA. Blood measurements of DHEA-S/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEA-S. A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones CONFIDENCE standard compound; EAWAG_UCHEM_ID 3085 D007155 - Immunologic Factors
Testosterone
Testosterone is the primary male sex hormone and anabolic steroid from the androstane class of steroids. It is the most important androgen in potency and quantity for vertebrates. In humans, testosterone plays a key role in the development of male reproductive tissues such as testes and prostate, as well as promoting secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair. In addition, testosterone is involved in health and well-being, and the prevention of osteoporosis. Testosterone exerts its action through binding to and activation of the androgen receptor. In mammals, testosterone is metabolized mainly in the liver. Approximately 50\\% of testosterone is metabolized via conjugation into testosterone glucuronide and to a lesser extent testosterone sulfate by glucuronosyltransferases and sulfotransferases. An additional 40\\% of testosterone is metabolized in equal proportions into the 17-ketosteroids androsterone and etiocholanolone via the combined actions of 5alpha- and 5beta-reductases, 3alpha-hydroxysteroid dehydrogenase, and 17beta-HSD. Like other steroid hormones, testosterone is derived from cholesterol. The first step in the biosynthesis of testosterone involves the oxidative cleavage of the side-chain of cholesterol by the cholesterol side-chain cleavage enzyme (P450scc, CYP11A1) to give pregnenolone. In the next step, two additional carbon atoms are removed by the CYP17A1 (17alpha-hydroxylase/17,20-lyase) enzyme to yield a variety of C19 steroids. In addition, the 3beta-hydroxyl group is oxidized by 3beta-hydroxysteroid dehydrogenase to produce androstenedione. In the final and rate limiting step, the C17 keto group androstenedione is reduced by 17beta-hydroxysteroid hydrogenase to yield testosterone. Testosterone is synthesized and released by the Leydig cells in the testes that lie between the tubules and comprise less than 5\\% of the total testicular volume. Testosterone diffuses into the seminiferous tubules where it is essential for maintaining spermatogenesis. Some testosterone binds to an androgen-binding protein (ABP) that is produced by the Sertoli cells and is homologous to the sex-hormone binding globulin that transports testosterone in the general circulation. The ABP carries testosterone in the testicular fluid where it maintains the activity of the accessory sex glands and may also help to retain testosterone within the tubule and bind excess free hormone. Some testosterone is converted to estradiol by Sertoli cell-derived aromatase enzyme. Leydig cell steroidogenesis is controlled primarily by luteinizing hormone with negative feedback of testosterone on the hypothalamic-pituitary axis. The requirement of spermatogenesis for high local concentrations of testosterone means that loss of androgen production is likely to be accompanied by loss of spermatogenesis. Indeed, if testicular androgen production is inhibited by the administration of exogenous androgens then spermatogenesis ceases. This is the basis of using exogenous testosterone as a male contraceptive. The largest amounts of testosterone (>95\\%) are produced by the testes in men, while the adrenal glands account for most of the remainder. Testosterone is also synthesized in far smaller total quantities in women by the adrenal glands, thecal cells of the ovaries, and, during pregnancy, by the placenta. Testosterone levels fall by about 1\\% each year in men. Therefore, with increasing longevity and the aging of the population, the number of older men with testosterone deficiency will increase substantially over the next several decades. Serum testosterone levels decrease progressively in aging men, but the rate and magnitude of decrease vary considerably. Approximately 1\\% of healthy young men have total serum testosterone levels below normal; in contrast, approximately 20\\% of healthy men over age 60 years have serum testosterone levels below normal. (PMID: 17904450, 17875487). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
2-Hydroxyestradiol
2-Hydroxyestradiol (2-OHE2), also known as estra-1,3,5(10)-triene-2,3,17beta-triol, is an endogenous steroid, catechol estrogen. 2-Hydroxyestradiol belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-hydroxyestradiol is considered to be a steroid molecule. It is a metabolite of estradiol, as well as a positional isomer of estriol. Transformation of estradiol to 2-hydroxyestradiol is a major metabolic pathway of estradiol in the liver. 2-Hydroxyestradiol is generated from estradiol via several cytochrome P450 enzymes. Specifically, CYP1A2 and CYP3A4 are the major enzymes catalyzing the 2-hydroxylation of estradiol. Conversion of estradiol into 2-hydroxyestradiol has been detected in the liver, uterus, breast, kidney, brain, and pituitary gland, as well as the placenta. 2-Hydroxyestradiol binds, with a low affinity, to estrogen receptors. 2-Hydroxyestradiol has approximately 7\\% and 11\\% of the affinity of estradiol at the estrogen receptors (ERs) ERalpha and ERbeta, respectively (PMID: 9048584). 2-Hydroxyestradiol is a catechol estrogen and in this regard bears some structural resemblance to the catecholamines dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) (PMID: 447670). In accordance, 2-hydroxyestradiol has been found to interact with catecholamine systems. The steroid is known to compete with catecholamines for binding to catechol O-methyltransferase and tyrosine hydroxylase and to competitively inhibit these enzymes (PMID: 447670). Inactivity of COMT blocks inactivation of catechol hormones and catecholamine neurotransmitters. 2-Hydroxyestradiol is also reported to inhibit angiongensis and tumor cell growth (PMID: 9472688). 2-Hydroxyestradiol is generated from estradiol by a Cytochrome P450. 2-Hydroxyestradiol binds, with a low affinity, to estrogen receptors. It inhbits catechol-O-methyltransferase (COMT) activity. Inactivity of COMT blocks inactivation of catechol hormones and catecholamine neutransmitters. 2-Hydroxyestradiol is also reported to inhibit angiongensis and tumor cell growth (PMID: 9472688). [HMDB] C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Estriol
Estriol is a metabolite of estrone metabolized via 16alpha-hydroxyestrone through the enzyme 16alpha-hydroxysteroid dehydrogenase (EC 1.1.1.147) or to 2- or 4-hydroxyestrone (catechol estrogens) by the action of catecho-O-methyltransferase (EC 2.1.1.6). The latter metabolites can be formed in the brain and may compete with receptors for catecholamines. Metabolites are conjugated with sulfate or glucuronide before excretion by the kidney. During pregnancy, estriol constitutes 60-70\\\\% of the total estrogens, increasing to 300-500-fold in relation to non-pregnant women. The late term human fetus produces relatively large amounts of 16 alphahydroxy DHEA, which serves the mother as a precursor of estriol. It has been shown that 90\\\\% of the precursors for the formation of estriol are of fetal origin. If abnormal maternal serum screening results, specifically low levels of unconjugated estriol in the second trimester are detected, a diagnosis of Smith-Lemli-Opitz syndrome (SLOS),or RSH is suspected. SLOS is an autosomal recessive disorder caused by mutations of the gene encoding 7-dehydrocholesterol reductase (EC 1.3.1.21, DHCR7). (PMID: 16202579, 16112271, 16097001). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CA - Natural and semisynthetic estrogens, plain G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CC - Estrogens, combinations with other drugs Estriol (also oestriol) is one of the three main estrogens produced by the human body. Estriol is found in common bean and pomegranate. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Estriol is a G protein-coupled estrogen receptor antagonist that can act on estrogen receptor-negative breast cancer cells. Estriol is a G protein-coupled estrogen receptor antagonist that can act on estrogen receptor-negative breast cancer cells.
Androstanedione
Androstanedione belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Thus, androstanedione is considered to be a steroid lipid molecule. Androstanedione is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. Androstanedione is a steroid metabolite and a procursor of both testosterone and estrone. It is a product of enzyme 3alpha-hydroxysteroid dehydrogenase [EC 1.1.1.50] in pathway Androgen and estrogen metabolism (KEGG). [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
4-Hydroxyestradiol
4-Hydroxyestradiol is an oncogenic catechol estrogen produced by metabolism of Estrogen. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones A human metabolite taken as a putative food compound of mammalian origin [HMDB]
4-Dihydroboldenone
4-Dihydroboldenone is a metabolite of boldenone. Boldenone is an androgenic anabolic steroid (AAS) intensively used for growth promoting purposes in animals destined for meat production and as a performance enhancer in athletics. Therefore its use is officially banned either in animals intended for consumption or in humans. Because most anabolic steroids are completely metabolized and usually no parent steroid is excreted, metabolite identification is crucial to detect the illegal use of anabolic steroids either in humans or in livestock. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. (PMID: 2663904, 16195040, 16292586, 1663826, 16799097, 16888758, 16923823, 9249887) [HMDB] 4-Dihydroboldenone is a metabolite of boldenone. Boldenone is an androgenic anabolic steroid (AAS) intensively used for growth-promoting purposes in animals destined for meat production and as a performance enhancer in athletics. Therefore, its use is officially banned in both humans and in animals intended for human consumption. Because most anabolic steroids are completely metabolized and usually no parent steroid is excreted, metabolite identification is crucial to detect the illegal use of anabolic steroids either in humans or in livestock. Androgenic anabolic steroids are defined as natural, synthetic, or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic, and neuroendocrine systems, the AAS has been extensively used in sports activities (PMID: 2663904, 16195040, 16292586, 1663826, 16799097, 16888758, 16923823, 9249887). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Etiocholanedione
Etiocholanedione is a 5-beta metabolite product of the catabolism of androgens. Etiocholanedione has been identified as a ketosteroid and isolated from the urine of healthy and diseased persons. Etiocholanedione has been identified as a metabolite of an altered androgen metabolism that eventually leads hepatocellular carcinoma to impaired hormone responsiveness in human. Etiocholanedione has been identified as a metabolite of 17alpha-hydroxyprogesterone in some patients affected by congenital adrenal hyperplasia, although it doesnt appear to account for the masculinization observed in congenital hyperplasia. Etiocholanedione can be the product of microbial contamination of urine since a few organisms are able to synthesize it using endogenous steroids as substrates. Human axillary bacteria are able to produce small amounts of etiocholanedione from testosterone. (PMID: 12161001, 13795320, 11161304, 2026727). Etiocholanedione has been found to be a metabolite of Corynebacterium (PMID: 11161304). Etiocholanedione is a 5-beta metabolite product of the catabolism of androgens. Etiocholanedione has been identified as a ketosteroid and isolated from the urine of healthy and diseased persons. Etiocholanedione has been identified as a metabolite of an altered androgen metabolism that eventually leads hepatocellular carcinoma to impaired hormone responsiveness in human. Etiocholanedione has been identified as a metabolite of 17alpha-hydroxyprogesterone in some patients affected by congenital adrenal hyperplasia, although it doesnt appear to account for the masculinization observed in congenital hyperplasia. Etiocholanedione can be the product of microbial contamination of urine since a few organisms are able to synthesize it using endogenous steroids as substrates. Human axillary bacteria are able to produce small amounts of etiocholanedione from testosterone. (PMID: 12161001, 13795320, 11161304, 2026727) [HMDB]
2-Polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone
This compound belongs to the family of Sesquiterpenes. These are terpenes with three consecutive isoprene units.
7alpha-hydroxyestradiol
7alpha-hydroxyestradiol, also known as Estra-1,3,5(10)-triene-3,7,17-triol or 7α-hydroxy-17β-estradiol, is classified as an estrogen or an Estrogen derivative. Estrogens are steroids with a structure containing a 3-hydroxylated estrane. 7alpha-hydroxyestradiol is considered to be practically insoluble (in water) and acidic
Arginylasparagine
Arginylasparagine is a dipeptide composed of arginine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Asparaginylarginine
Asparaginylarginine is a dipeptide composed of asparagine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
16b-Hydroxyestradiol
16b-Hydroxyestradiol, which is better known as epiestriol (or 16beta-epiestriol or 16beta-hydroxy-17beta-estriol), belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, epiestriol is considered to be a steroid molecule. Formally 16b-hydroxyestradiol is a 3-hydroxy steroid that is 17beta-estradiol substituted by a beta-hydroxy group at position 16. In other words, it has hydroxyl groups at the C3, 16-beta, and 17-beta positions. It is an oxidative metabolite of 17beta-estradiol (PMID: 12865317). Epiestriol is found in all vertebrates. Epiestriol is a minor and weak endogenous estrogen. It is the 16beta-epimer of estriol (which is 16alpha-hydroxy-17beta-estradiol). Epiestriol has been used clinically in the treatment of acne. In addition to its estrogenic actions, epiestriol has been found to possess significant anti-inflammatory properties without glycogenic activity or immunosuppressive effects (PMID: 9120824). A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. [HMDB] C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
17-Epiestriol
17-Epiestriol, also known as 17alpha-estriol, belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 17-epiestriol is considered to be a steroid lipid molecule. 17-Epiestriol is a hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at the C3-beta, 16-alpha, and 17-beta positions. Estriol is a major urinary estrogen. During pregnancy, a large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. [HMDB]
16,17-Epiestriol
16,17-Epiestriol is a hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-, and 17- position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol (16-beta, 17-alpha). A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-, and 17- position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol (16-beta, 17-alpha). [HMDB]
Epitestosterone
Epitestosterone, or isotestosterone, also known as 17alpha-testosterone or as androst-4-en-17alpha-ol-3-one belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. Epitestosterone is an endogenous steroid and a C-17 epimer of the androgen sex hormone testosterone. It is a weak competitive antagonist of the androgen receptor (AR) and a potent 5alpha-reductase inhibitor. Structurally, epitestosterone differs from testosterone only in the configuration at the hydroxy-bearing carbon, C17. Epitestosterone is believed to form in a similar way to testosterone with 50\\% of epitestosterone production in human males taking place in the testis. Epitestosterone levels are typically highest in young males; however, by adulthood, most healthy males exhibit a testosterone to epitestosterone ratio (T/E ratio) of about 1:1 (PMID: 11901061). A study of Australian athletes found that the mean T/E ratio in the study was 1.15:1. Another study found that the max T/E ratio for the 95th percentile of athletes was 3.71:1, and the max T/E ratio for the 99th percentile was 5.25:1. Epitestosterone has not been shown to enhance athletic performance, although administration of epistestosterone can be used to mask a high level of testosterone if the standard T/E ratio test is used. As such, epitestosterone is banned by many sporting authorities as a masking agent for testosterone. Interestingly, small amounts of ethanol can elevate T/E values, with women being more susceptible (PMID: 28671321). Testosterone is a steroid hormone from the androgen group and is found in mammals, reptiles, birds, and other vertebrates. In mammals, testosterone is primarily secreted in the testicles of males and the ovaries of females, although small amounts are also secreted by the adrenal glands. It is the principal male sex hormone and an anabolic steroid. [Wikipedia]. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Dehydroandrosterone
Dehydroandrosterone is a normal human androgen. It has been found dehydroandrosterone and other androgens excretion is affected by seasonal rhythms changes. In a study of patients with peptic ulcer in the stage of remission, their androgen levels were higher both in summer and winter, but in the spring their levels are higher in normal subjects. There is a high correlation between Dehydroandrosterone excretion and testosterone; this ratio is also used as an aid for a better discrimination between physiologically high and pharmacologically high ratios of testosterone in sports. (PMID: 3157236, 9001956, 10774538) [HMDB] Dehydroandrosterone is a normal human androgen. It has been found dehydroandrosterone and other androgens excretion is affected by seasonal rhythms changes. In a study of patients with peptic ulcer in the stage of remission, their androgen levels were higher both in summer and winter, but in the spring their levels are higher in normal subjects. There is a high correlation between Dehydroandrosterone excretion and testosterone; this ratio is also used as an aid for a better discrimination between physiologically high and pharmacologically high ratios of testosterone in sports. (PMID: 3157236, 9001956, 10774538).
6-Hydroxypentadecanedioic acid
6-Hydroxypentadecanedioic acid is found in green vegetables. 6-Hydroxypentadecanedioic acid is a constituent of Gnetum gnemon (bago) Constituent of Gnetum gnemon (bago). 6-Hydroxypentadecanedioic acid is found in nuts and green vegetables.
Sakacin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D001430 - Bacteriocins Sakacin A is produced by Lactobacillus sake LB70 Production by Lactobacillus sake LB706
alpha-Amylcinnamyl isovalerate
alpha-Amylcinnamyl isovalerate is a flavouring ingredien Flavouring ingredient
O-Geranylvanillin
O-Geranylvanillin is found in green vegetables. O-Geranylvanillin is a constituent of rock samphire (Crithmum maritimum). Constituent of rock samphire (Crithmum maritimum). O-Geranylvanillin is found in green vegetables.
4-hydroxystradiol
4-hydroxystradiol is a metabolite of estradiol. Estradiol (E2 or 17β-estradiol, also oestradiol) is a sex hormone. Estradiol is abbreviated E2 as it has 2 hydroxyl groups in its molecular structure. Estrone has 1 (E1) and estriol has 3 (E3). Estradiol is about 10 times as potent as estrone and about 80 times as potent as estriol in its estrogenic effect. Except during the early follicular phase of the menstrual cycle, its serum levels are somewhat higher than that of estrone during the reproductive years of the human female. (Wikipedia)
1,3,5[10]-Estratriene-2,3-17 beta-triol
Arginine ornithine
C11H24N6O3 (288.19097939999995)
7A-Methyl-19-nortestosterone
(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
(8S,9R,10S,13S,14S)-10,13-Dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione
Psoracorylifol B
4-[(1R,2S,5S,7R)-2-ethenyl-2-methyl-5-propan-2-yl-6,8-dioxabicyclo[3.2.1]octan-7-yl]phenol is a natural product found in Helicobacter pylori with data available.
Pipataline
A member of the class of benzodioxoles that is 1,3-benzodioxole in which the hydrogen at position 5 has been replaced by a dodec-1-en-1-yl group.
(6S,7E,9E,11E)-3-Oxo-13-apo-alpha-caroten-13-one
1beta,14-dihydroxy-13-methoxy-6,8,11,13-podocarpatetraene
14-hydroxy-13-methoxy-8,11,13-podocarpatrien-7-one
(E)-2,4-dihydroxy-3-(3,7-dimethyl-2,6-octadienyl)-6-methylbenzaldehyde|3-geranylorcylaldehyde|colletorin B
19-norisopimara-4(18),8(14),15-triene-7alpha,17-diol
11beta-11-Hydroxy-20-nor-8,15-isopimaradien-7-one|11beta-hydroxy-20-nor-8(9),15-isopimaradien-7-one
(E)-3-(3,7-dimethyl-2,6-octadienyl)-4-methoxybenzoic acid
3-(hydroxyisopent-2(E)-enyl)-5-(isopent-2-enyl)-4-hydroxyacetophenone|3--5-(isopent-2-enyl)-4-hydroxyacetophenone|4-hydroxy-5-(2-isopentenyl)-3-(4-hydroxy-2-isopentenyl)-acetophenone
17-norphyllocladane-3,16-dione|3-Oxonorphyllocladanon
Me ester-(15E,8Z)-3-Hydroxy-8,15-heptadecadiene-11,13-diynoic acid
rel-(5beta,8alpha,10alpha)-8-hydroxy-13-methylpodocarpa-9(11),13-diene-3,12-dione
17,18-Epoxy-14-nor-8,10,15-lobatrien-13-one|17,18-epoxy-14-norloba-8,10,15-trien-13-one
Undecan-1,2,11-tricarbonsaeure|undecane-1,2,11-tricarboxylic acid
Di-Me ether-(E,E)-1-(3,4-Dihydroxyphenyl)-1,3-decadien-5-one
18-norabieta-8,11,13-trien-4-hydroperoxide|4-hydroperoxy-18-nor-dehydroabietane
docos-3c-ene-1,11,13,15,21-pentayne|Siphonochalin|Siphonochalyne
9,12,15-octadecatrien-6-ynoic acid methyl ester|dicranin methyl ester|Methyl-9,12,15-octadecatrien-6-ynoat
(5beta,10alpha)-12-hydroxy-13-methoxypodocarpa-8,11,13-trien-3-one
(5beta,10alpha)-13-hydroxy-12-methoxypodocarpa-8,11,13-trien-3-one
(S)-4-hydroxy-4-(2Z,5Z,8Z-tetradeca-2,5,8-trienyl)cyclopent-2-en-1-one|homaxinone A
(4aR,6aS,8S,9R,11aR,11bR)-tetradecahydro-11b-methyl-4-methylidene-6a,9-methanocyclohepta[a]naphthalene-8-carboxylic acid|18-nor-ent-kaur-4(19)-en-17-oic acid
(E)-17-methyl-9-octadecen-5,7-diynoic acid|heterofibrin B1
4,12-dihydroxy-13-acetyl-19-nor-8,11,13-podocarpatriene
(Z)-2-(hexadeca-13,15-dien-2,4-diynyloxy)acetic acid|montiporic acid D
(1aR,2E,4aR,6S,7S,7aR,9Z,11aS)-1,1a,4a,5,6,7,7a,8,11,11a-decahydro-7-hydroxy-1,1,6,9-tetramethyl-4H-cyclopenta[a]cyclopropa[f] [11]annulen-4-one
6-acyloxyfuranoeremophil-1(10)-ene|6beta-propanoyloxyeuryopsin
6beta,12-dihydroxy-13-methyl-ent-podocarp-8,11,13-trien-3-one
(1R*,2R*,3R*,6R*,7R*)1,2,3,6,7-Pentahydroxy-bisabol-10(11)-ene
Estra-1,3,5(10)-triene-3,15,17-triol, (15.alpha.,17.beta.)-
(5beta,10alpha)-12-hydroxy-3,4-seco-podocarpa-4(18),8,11,13-tetraen-3-oic acid A 3-methyl ester|moluccanic acid methyl ester
(4aR,7R,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-8-[3-methylenebut-4-alyl]-4,4a,7,8-tetramethylnaphthalen-2(1H)-one
3-(2-hydroxy-3-methyl-3-butenyl)-5-(3-methyl-2-butenyl)-4-hydroxyacetophenone
13,15-epoxy-19-norloba-8,10,16-trien-18-one|13,15-epoxy-19-norloba-8,10,16-triene-18-one|13,15-Epoxy-20-nor-8,10,16-lobatrien-18-one
(1R,6R,10R,12R)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0^{2,6]tetradec-2-en-4-one
3,5-Bis(3-methyl-2-butenyl)-4-hydroxybenzoic acid methyl ester
5-acetyl-2-(2-hydroxyisopropyl)-7-(3,3-dimethylallyl)-2,3-dihydrobenzofuran
9,10-epoxy-16-hydroxyoctadeca-17-ene-12,14-diyne-1-al
Dendrotrifidic acid|R-(-)-16-Hydroxy-cis-9,17-octadecadien-12,14-diin-saeure
(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methyl-benzene|(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene
Fischeria A
Psoracorylifol C
Dehydroepiandrosterone
An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.269 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.
Testosterone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid Origin: Animal; SubCategory_DNP: The sterols, Androstanes CONFIDENCE standard compound; INTERNAL_ID 2802 CONFIDENCE standard compound; INTERNAL_ID 4160 CONFIDENCE standard compound; INTERNAL_ID 8730 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.
Estriol
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CA - Natural and semisynthetic estrogens, plain G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03C - Estrogens > G03CC - Estrogens, combinations with other drugs A 3-hydroxy steroid that is estra-1,3,5(10)-trien-3-ol substituted by additional hydroxy groups at positions 16 and 17 (16alpha,17beta-stereoisomer). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2392 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong. Estriol is a G protein-coupled estrogen receptor antagonist that can act on estrogen receptor-negative breast cancer cells. Estriol is a G protein-coupled estrogen receptor antagonist that can act on estrogen receptor-negative breast cancer cells.
2-Hydroxyestradiol
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
16-Epiestriol
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
17-Epiestriol
A 16alpha-hydroxy steroid that is estriol in which the hydroxy group at position 17 has been epimersied from beta- to alpha- configuration. It is a metabolite of estradiol and a selective estrogen receptor beta (ER-beta) agonist.
Epitestosterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones An androstanoid that is the C-17 epimer of testosterone.
Androstanedione
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Prasterone
A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D007155 - Immunologic Factors
1,2-Dihexanoyl-sn-glycerol
A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as hexanoyl.
17a-Estriol
Sakacin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D001430 - Bacteriocins
ascr#13
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,6R)-6-hydroxyhept-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
ST 18:3;O3
A 4-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 4. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
ST 19:2;O2
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Phenglutarimid
C17H24N2O2 (288.18376839999996)
N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
TERT-BUTYL ((1R,5S,6S)-3-BENZYL-3-AZABICYCLO[3.1.0]HEXAN-6-YL)CARBAMATE
C17H24N2O2 (288.18376839999996)
TERT-BUTYL 3-(1-AMINO-2-METHYLPROPAN-2-YL)-1H-INDOLE-1-CARBOXYLATE
C17H24N2O2 (288.18376839999996)
tert-Butyl4-(3-cyano-2-pyridinyl)-1-piperazinecarboxylate
benzyl 1,9-diazaspiro[5.5]undecane-9-carboxylate
C17H24N2O2 (288.18376839999996)
(s)-n-[4-benzyl)piperidino]proline
C17H24N2O2 (288.18376839999996)
2-PYRROLIDIN-1-YLMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER
C17H24N2O2 (288.18376839999996)
3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester
C14H28N2O4 (288.20489680000003)
methyl (1R)-6-hydroxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophena nthrene-1-carboxylate
1,3-bis[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]urea
4,7,13,18-tetraoxa-1,10-diazabicyclo[8.5.5]icosane
C14H28N2O4 (288.20489680000003)
N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)cyclopropanecarboxamide
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE
1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]pyrrolidin-2-one
N-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinamide
1-cyclopropyl-N-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]methyl]methanamine
tert-Butyl spiro[indoline-3,4-piperidine]-1-carboxylate
C17H24N2O2 (288.18376839999996)
tert-Butyl 4-(4-cyanopyrid-2-yl)piperazine-1-carboxylate
ethyl 4,4-diethoxy-2-(ethoxymethylidene)-3-oxopentanoate
trans-4-Propylcyclohexanecarboxylic acid 4-propylphenyl ester
Methyl 1-[4-(2-methyl-2-propanyl)phenyl]-4-oxocyclohexanecarboxyl ate
Diisopropyl 3,3-dimethoxycyclobutane-1,1-dicarboxylate
2-(chloromethyl)oxirane,2-(hydroxymethyl)-2-methylpropane-1,3-diol
Tert-Butyl Spiro[Indoline-3,4-Piperidine]-1-Carboxylate
C17H24N2O2 (288.18376839999996)
2-(tert-Butyl)-4-(piperazin-1-yl)-6-(trifluoromethyl)pyrimidine
C13H19F3N4 (288.15617299999997)
2,6-DI-TERT-BUTYL-4-METHYLPHENYLDIAZO ACETATE
C17H24N2O2 (288.18376839999996)
2-PYRROLIDIN-1-YLMETHYL-PYRROLIDINE-1-CARBOXYLICACIDBENZYLESTER
C17H24N2O2 (288.18376839999996)
Lidocaine HCl
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D049990 - Membrane Transport Modulators
1H-PYRROLO[2,3-B]PYRIDINE, 5-METHYL-1-[TRIS(1-METHYLETHYL)SILYL]-
1,3,5-Pentanetricarboxylicacid, 1,3,5-triethyl ester
(S)-3-BOC-4-(METHOXYMETHYLCARBAMOYL)-2,2-DIMETHYLOXAZOLIDINE
tert-butyl (1S,4S)-5-benzyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
C17H24N2O2 (288.18376839999996)
ethyl 4-(1H-benzimidazol-2-ylamino)piperidine-1-carboxylate
TERT-BUTYL (3-BENZYL-3-AZABICYCLO[3.1.0]HEXAN-6-YL)CARBAMATE
C17H24N2O2 (288.18376839999996)
1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CYCLOPROPANECARBOXYLIC ACID
(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
Trestolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
4-(4-Tetrahydropyranyl)phenylboronic Acid Pinacol Ester
2-(Piperidino)pyridine-5-boronic acid pinacol ester
2,2-(1,2-Diazenediyl)bis[N-(2-hydroxyethyl)-2-methylpropanamide
1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERAZINE
(R)-3-BOC-4-(METHOXYMETHYLCARBAMOYL)-2,2-DIMETHYLOXAZOLIDINE
2-allyl-1,1,1,3,3,3-hexamethyl-2-(trimethylsilyl)trisilane
C12H32Si4 (288.15809920000004)
1-BOC-6-BENZYL-2,6-DIAZASPIRO[3.3]HEPTANE
C17H24N2O2 (288.18376839999996)
4-[2-(DipropylaMino)ethyl]-3-Methoxyindol-2-one
C17H24N2O2 (288.18376839999996)
2-(3-(Cyclopropylmethoxy)-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, phenylmethyl ester
C17H24N2O2 (288.18376839999996)
1-(Methoxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
bis[2-(dimethylamino)ethyl] hexanedioate
C14H28N2O4 (288.20489680000003)
Estra-1(10),2,4-triene-2,3,17-triol
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
17-Hydroxyandrost-4-en-3-one
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
15alpha-Hydroxyestradiol
A 3-hydroxy steroid that is 17beta-estradiol substituted by an alpha-hydroxy group at position 15. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Androstane-3,17-dione
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones An androstanoid that is androstane substituted by oxo groups at positions 3 and 17.
Normethandrone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DC - Estren derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone ATC code: G03DC31
4-[(1S,2S,5S)-5-(Hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-EN-2-YL]phenol
Teslen
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
Methyl 6-(pentacyclo[6.4.0.0(2,7).0(3,6).0(9,12)]dodec-4-yl)hexanoate
(8R,9S,13S,14R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
(2r)-2,4-Dihydroxy-3,3-Dimethyl-N-[3-Oxo-3-(Pentylamino)propyl]butanamide
C14H28N2O4 (288.20489680000003)
7alpha-hydroxyestradiol
A 7alpha-hydroxy steroid that is 17beta-estradiol substituted by an alpha-hydroxy group at position 7. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
[3-carboxy-2-[(E)-3-hydroxyhept-4-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxyhept-5-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-2-hydroxyhept-5-enoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-(3-oxoheptanoyloxy)propyl]-trimethylazanium
CID 122130603
D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials
(13S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
(3S,10R,13S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Diethylaminoacet-2,6-xylidide hydrochloride monohydrate
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators
2,3-Dihexanoyl-sn-glycerol
A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as caproyl (hexanoyl).
3-(4-phenylphenyl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine
[(1S,4R)-4-[2-amino-6-(isopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
(2E)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]oct-2-enoic acid
N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]cyclopentanecarboxamide
C17H24N2O2 (288.18376839999996)
[(1S,2aR,8bR)-2-(4-oxanylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
C17H24N2O2 (288.18376839999996)
[(1S,2aS,8bS)-2-(4-oxanylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
C17H24N2O2 (288.18376839999996)
N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]cyclopentanecarboxamide
C17H24N2O2 (288.18376839999996)
[(1R,2aS,8bS)-2-(4-oxanylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
C17H24N2O2 (288.18376839999996)
[(1R,2aR,8bR)-2-(4-oxanylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol
C17H24N2O2 (288.18376839999996)
Virormone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Ethyl (4R*,5R*)-(E)-4-hydroxy-5-(tert-butyldimethylsilyl)oxy-2-hexenoate
(1E,7E,11E)-1-Acetyl-3,4-epoxy-4,8,12-trimethylcyclotetrdecatriene
(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoic acid
Ethyl (4R*,5R*)-(E)-5-hydroxy-4-(tert-butyldimethylsilyl)oxy-2-hexenoate
(4AS,5S,8AS)-(+)-5beta,8Abeta-dimethyl-2-formyl-5alpha-(4-methyl-3-pentenyl)-4A,5,6,7,8,8A-hexahydronaphthalen-1(4H)-one
(13S,16R,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
3-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methoxy-2-methylcyclohexa-2,5-diene-1,4-dione
Epiestriol
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
17beta-Hydroxy-5beta-androst-1-en-3-one
A 3-oxo Delta(1)-steroid with 5beta-configuration formed from 17beta-hydroxyandrosta-1,4-dien-3-one by reduction across the C4-C5 double bond.
oscr#13
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-8-oct-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
5alpha-androstane-3,17-dione
The 5alpha-stereoisomer of androstane-3,17-dione.
5beta-androstane-3,17-dione
An androstane-3,17-dione with a 5beta-configuration.
2-Hydroxy-17beta-estradiol
A 2-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 2.
16beta-Hydroxyestradiol
A 3-hydroxy steroid that is 17beta-estradiol substituted by a beta-hydroxy group at position 16.
S 38093
C17H24N2O2 (288.18376839999996)
S 38093 is a brain-penetrant, orally active antagonist of H3 receptor, with Kis of 8.8, 1.44 and 1.2 μM for rat, mouse and human H3 receptors, respectively.
7-ethenyl-4b,10-dihydroxy-1,1-dimethyl-3,4,4a,5,6,7-hexahydro-2h-phenanthren-9-one
8-hydroxy-7-methoxy-1,1,4a-trimethyl-3,4,10,10a-tetrahydro-2h-phenanthren-9-one
(4as,10ar)-7-hydroxy-6-methoxy-1,1,4a-trimethyl-4,9,10,10a-tetrahydro-3h-phenanthren-2-one
2-methoxy-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-1,4-dione
(1s,2s,3s,4s)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4-methylcyclohexane-1,2,3,4-tetrol
4-hydroxy-3,5,5-trimethyl-4-(3-methyl-7-oxoocta-1,3,5-trien-1-yl)cyclohex-2-en-1-one
(1r,4s,9s,10s,13s)-5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one
7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one
7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol
(1r,6r)-1,4,4,6,9-pentamethyl-1h,2h,5h,6h-naphtho[2,1-c]pyran-7,8-diol
3-[(1e)-hept-1-en-1-yl]-2-(hydroxymethyl)-4-(3-methylbut-2-en-1-yl)phenol
(1r,4as,9r,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1,9-diol
(4ar,8as,10as)-8a-hydroxy-1,1,4a,7-tetramethyl-4,9,10,10a-tetrahydro-3h-phenanthrene-2,6-dione
methyl 2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboxylate
(3s,4r)-3-(1,8-dihydroxy-8-methylnonyl)-4-(hydroxymethyl)oxolan-2-one
methyl 4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)benzoate
4-{2-ethenyl-5-isopropyl-2-methyl-6,8-dioxabicyclo[3.2.1]octan-7-yl}phenol
7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-hexahydro-1h-azulene-3a,4,8a-triol
[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-ylidene]acetic acid
[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene]acetic acid
(1r*,2r*,3r*,6r*,7r*)1,2,3,6,7-pentahydroxy-bisabol-10(11)-ene
{"Ingredient_id": "HBIN003041","Ingredient_name": "(1r*,2r*,3r*,6r*,7r*)1,2,3,6,7-pentahydroxy-bisabol-10(11)-ene","Alias": "NA","Ingredient_formula": "C15H28O5","Ingredient_Smile": "CC(=CCCC(C)(C1(CCC(C(C1O)O)(C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16827","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-(3',7'-dimethyl-2',6'-octadienyl)-4-methoxy-benzoicacid
{"Ingredient_id": "HBIN007151","Ingredient_name": "3-(3',7'-dimethyl-2',6'-octadienyl)-4-methoxy-benzoicacid","Alias": "NA","Ingredient_formula": "C18H24O3","Ingredient_Smile": "CC(=CCCC(=CCC1=C(C=CC(=C1)C(=O)O)OC)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6382","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3alpha-hydroxy-androst-4-ene-17-one
{"Ingredient_id": "HBIN007952","Ingredient_name": "3alpha-hydroxy-androst-4-ene-17-one","Alias": "3\u03b1-hydroxy-androst-4-ene-17-one","Ingredient_formula": "C19H28O2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31145;9781","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-hydroxyandrost-9(11)-en-17-one
{"Ingredient_id": "HBIN008694","Ingredient_name": "3-hydroxyandrost-9(11)-en-17-one","Alias": "NA","Ingredient_formula": "C19H28O2","Ingredient_Smile": "NA","Ingredient_weight": "288.42","OB_score": "NA","CAS_id": "14043-47-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8085","PubChem_id": "NA","DrugBank_id": "NA"}
5 beta-androstan-3,17-dione
{"Ingredient_id": "HBIN011458","Ingredient_name": "5 beta-androstan-3,17-dione","Alias": "5\u03b2-androstan-3,17-dione","Ingredient_formula": "C19H28O2","Ingredient_Smile": "CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30601;1166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5 beta-androstan-3 alpha,17 beta-diol
{"Ingredient_id": "HBIN011460","Ingredient_name": "5 beta-androstan-3 alpha,17 beta-diol","Alias": "5\u03b2-androstan-3\u03b1,17\u03b2-diol","Ingredient_formula": "C19H28O2","Ingredient_Smile": "CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30599;1164","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one
n-[3-(6,7-dimethoxyisoquinolin-1-yl)propyl]guanidine
2-(2-hydroxy-6-methylhept-5-en-2-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
C17H24N2O2 (288.18376839999996)
7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one
(1r,3s,3as,4r,7r,8ar)-7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-octahydroazulene-1,3,4-triol
(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol
1-[(1r,5z,9s,10s)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione
5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
1-{3'-hydroxy-2',2',6'-trimethyl-3h-spiro[1-benzofuran-2,1'-cyclohexan]-5-yl}ethanone
(1r,3as,4r,7r,8as)-7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-hexahydro-2h-azulene-1,4,8a-triol
(1r,4as,10ar)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-ol
(7e)-7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one
methyl (9z,12z,15z)-octadeca-9,12,15-trien-6-ynoate
7-hydroxy-6-methoxy-1,1,4a-trimethyl-4,9,10,10a-tetrahydro-3h-phenanthren-2-one
1-[(1s,5e,9r,10r)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione
(5s)-5-methyl-3-[(1e,11e)-tetradeca-1,11,13-trien-1-yl]-5h-furan-2-one
(4s,4as,11ar)-7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one
5-(2,6,8-trimethyl-3-oxo-4a,5,6,7,8,8a-hexahydro-4h-naphthalen-1-yl)penta-2,4-dienoic acid
1-[(2s)-2-(2-hydroxypropan-2-yl)-7-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
3-(4-cyclopropyl-2-methylbuta-1,3-dien-1-yl)-1,2,8-trihydroxy-1-methyl-2,3-dihydro-4λ⁵-indolizin-4-ylium
(4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene)acetic acid
(1r,10s,12s)-5,11,11-trimethyl-13-oxatetracyclo[10.2.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5-triene-4,12-diol
5-(6-hydroxy-2,6,8-trimethyl-5,7,8,8a-tetrahydro-4ah-naphthalen-1-yl)penta-2,4-dienoic acid
(1r,4as,4bs,7r,10as)-7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one
3-amino-3-({1-[n-tert-butyl-n-methyl-(c-hydroxycarbonimidoyl)amino]ethyl}-c-hydroxycarbonimidoyl)propanoic acid
4-[(1s,2s,5r,7s)-2-ethenyl-5-isopropyl-2-methyl-6,8-dioxabicyclo[3.2.1]octan-7-yl]phenol
(4as,10as)-8-hydroxy-7-methoxy-1,1,4a-trimethyl-3,4,10,10a-tetrahydro-2h-phenanthren-9-one
3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-6-methylbenzaldehyde
(3s,4ar,10as)-7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol
4-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-2-methylidenebutanal
n-{4-[(1-hydroxy-2-methylpropylidene)amino]butyl}-3-phenylprop-2-enimidic acid
C17H24N2O2 (288.18376839999996)
(4bs,5r,8as)-2-methoxy-4b,8,8-trimethyl-5,6,7,8a-tetrahydrophenanthrene-1,5-diol
6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one
3-(1,8-dihydroxy-8-methylnonyl)-4-(hydroxymethyl)oxolan-2-one
3-(3,7-dimethylocta-2,6-dien-1-yl)-4-methoxybenzoic acid
1-[(2r,3'r,6's)-3'-hydroxy-2',2',6'-trimethyl-3h-spiro[1-benzofuran-2,1'-cyclohexan]-5-yl]ethanone
3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-methylbenzaldehyde
4-[(s)-[(2s,3s,6s)-3-ethenyl-3-methyl-6-(prop-1-en-2-yl)oxan-2-yl](hydroxy)methyl]phenol
1-[5-acetyl-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-methylbutan-1-one
8a-hydroxy-1,1,4a,7-tetramethyl-4,9,10,10a-tetrahydro-3h-phenanthrene-2,6-dione
(2e,4e,9z)-heptadeca-2,4,9-trien-6-yn-1-yl acetate
7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one
7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-hexahydro-2h-azulene-1,4,8a-triol
(4e,6s,11r)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one
(1s,3as,4ar)-1-hydroxy-1-isopropyl-3a,5-dimethyl-2h,3h,4h,4ah,8ah,10h,10ah-cyclohexa[f]azulen-9-one
(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-6-methyloctylidene]amino}-3-methylbutanoic acid
C14H28N2O4 (288.20489680000003)
(1r,4s,5s,9s,10s,13r)-5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
(1s,2s,4s,4ar,6r,8as)-6-(1,2-dihydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalene-1,2,4a-triol
2-methoxy-4b,8,8-trimethyl-5,6,7,8a-tetrahydrophenanthrene-1,5-diol
2-hydroxy-6-(7-hydroxyundeca-1,3-dien-1-yl)benzaldehyde
(3as,6as)-2-[(1e,3r)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one
1-[2-(2-hydroxypropan-2-yl)-7-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
(4s)-4-hydroxy-3,5,5-trimethyl-4-[(1e)-3-methyl-7-oxoocta-1,3,5-trien-1-yl]cyclohex-2-en-1-one
(2r)-2-(2-hydroxy-6-methylhept-5-en-2-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
C17H24N2O2 (288.18376839999996)
(4bs)-7-ethenyl-4b,10-dihydroxy-1,1-dimethyl-3,4,4a,5,6,7-hexahydro-2h-phenanthren-9-one
5-(2,6,8-trimethyl-1-oxo-4a,5,6,7,8,8a-hexahydronaphthalen-2-yl)penta-2,4-dienoic acid
methyl (3r,11r)-3-(acetyloxy)-11-hydroxydodecanoate
(3as,6as)-2-[(1e)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one
1-{4-hydroxy-3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-5-(3-methylbut-2-en-1-yl)phenyl}ethanone
(2e)-n-{4-[(1-hydroxy-2-methylpropylidene)amino]butyl}-3-phenylprop-2-enimidic acid
C17H24N2O2 (288.18376839999996)
(1r,2r,3r,4r)-1-[(2r)-2-hydroxy-6-methylhept-5-en-2-yl]-4-methylcyclohexane-1,2,3,4-tetrol
4-{[3-ethenyl-3-methyl-6-(prop-1-en-2-yl)oxan-2-yl](hydroxy)methyl}phenol
(1s,2s,3s)-3-[(1e,3e)-4-cyclopropyl-2-methylbuta-1,3-dien-1-yl]-1,2,8-trihydroxy-1-methyl-2,3-dihydro-4λ⁵-indolizin-4-ylium
(2e,4e)-5-(2,6,8-trimethyl-1-oxo-4a,5,6,7,8,8a-hexahydronaphthalen-2-yl)penta-2,4-dienoic acid
1-(6-hydroxydeca-1,3-dien-1-yl)-1,3-dihydro-2-benzofuran-4-ol
2-hydroxy-6-[(1e,3e,7r)-7-hydroxyundeca-1,3-dien-1-yl]benzaldehyde
2-[(3-amino-1,2-dihydroxy-6-methyloctylidene)amino]-3-methylbutanoic acid
C14H28N2O4 (288.20489680000003)
1-{4-hydroxy-3-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-5-(3-methylbut-2-en-1-yl)phenyl}ethanone
(1s,3ar,4r,7r,8ar)-7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-hexahydro-1h-azulene-3a,4,8a-triol
(4s,4ar,5s)-3,4a,5-trimethyl-4-propoxy-4h,5h,6h,7h-naphtho[2,3-b]furan-9-one
1-{4-hydroxy-3-[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]-5-(3-methylbut-2-en-1-yl)phenyl}ethanone
7-(1,2-dihydroxypropan-2-yl)-1,4-dimethyl-octahydroazulene-1,3,4-triol
1,4,4,6,9-pentamethyl-1h,2h,5h,6h-naphtho[2,1-c]pyran-7,8-diol
(2e,4e)-5-[(4ar,6r,8r,8as)-6-hydroxy-2,6,8-trimethyl-5,7,8,8a-tetrahydro-4ah-naphthalen-1-yl]penta-2,4-dienoic acid
methyl 4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-hydroxybenzoate
4-methoxy-3,5-bis(3-methylbut-2-en-1-yl)benzoic acid
(2e,4e)-5-[(4ar,6s,8s,8ar)-2,6,8-trimethyl-3-oxo-4a,5,6,7,8,8a-hexahydro-4h-naphthalen-1-yl]penta-2,4-dienoic acid
(4s)-4-hydroxy-3,5,5-trimethyl-4-[(1e,3e,5e)-3-methyl-7-oxoocta-1,3,5-trien-1-yl]cyclohex-2-en-1-one
1-[(1e,3e)-6-hydroxydeca-1,3-dien-1-yl]-1,3-dihydro-2-benzofuran-4-ol
methyl 4-(3,7-dimethylocta-2,6-dien-1-yl)-3-hydroxybenzoate
(2e,4z)-5-[(2s,4ar,6s,8s,8as)-2,6,8-trimethyl-1-oxo-4a,5,6,7,8,8a-hexahydronaphthalen-2-yl]penta-2,4-dienoic acid
3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-methoxybenzoic acid
(2r)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2,3-dihydro-1h-indole-5-carboximidic acid
C17H24N2O2 (288.18376839999996)
